Publications by authors named "J H Haw"
Article Synopsis
- Transgender women (TW) face significant challenges with HIV, and there's a growing interest in using digital methods for HIV research, though bias between digital and site-based data collection is under-explored.
- A study involving 1,312 TW in the eastern and southern USA compared characteristics of those participating in site-based versus digital modes, focusing on demographics, healthcare access, and mental health factors.
- Results indicated that site-based participants were generally younger, more likely to identify as people of color, and had different experiences and risks related to HIV compared to those who participated online, suggesting that a hybrid approach may provide a more representative sample for research.
Background: In the United States, transgender women are disproportionately impacted by HIV and prioritized in the national strategy to end the epidemic. Individual, interpersonal, and structural vulnerabilities underlie HIV acquisition among transgender women and fuel syndemic conditions, yet no nationwide cohort monitors their HIV and other health outcomes.
Objective: Our objective is to develop a nationwide cohort to estimate HIV incidence, identify risk factors, and investigate syndemic conditions co-occurring with HIV vulnerability or acquisition among US transgender women.
Context: The long-term effect of gender-affirming hormone therapy (GAHT) on glucose metabolism is an area of priority in transgender health research.
Objectives: To evaluate the relation between GAHT and changes in fasting blood glucose (FG) and glycosylated hemoglobin (HbA1c) in transmasculine (TM) and transfeminine (TF) persons relative to the corresponding temporal changes in presumably cisgender persons (ie, without any evidence of gender diversity).
Design: Retrospective cohort study.
Background: Most high-risk neuroblastoma patients who relapse succumb to disease despite the existing therapy. We recently reported increased event-free and overall survival in neuroblastoma patients receiving difluoromethylornithine (DFMO) during maintenance therapy. The effect of DFMO on cellular processes associated with neuroblastoma tumorigenesis needs further elucidation.
View Article and Find Full Text PDFBackground And Objectives: Two-Spirit, trans, nonbinary and other gender-diverse (2STGD) donors face challenges in donation. While many blood operators aim to address these challenges, to date, no empirical study with these donors has been conducted to guide their efforts. This paper reports 2STGD donors' views on a two-step approach asking donors their gender and sex assigned at birth (SAAB), and expanding gender options in donor registration.
View Article and Find Full Text PDF